Page: Core summary of product characteristics for human normal immunoglobulin for subcutaneous and intramuscular use - Scientific guideline-2026/4/9

Regulatory and procedural guideline: EudraVigilance registration documents (updated)-2023/01/04

关于《腺相关病毒载体类体内基因治疗产品临床试验申请药学研究与评价技术指导原则（征求意见稿）》征求意见的通知-2023/7/25

国家药监局关于发布仿制药参比制剂目录（第七十六批）的通告（2024年第8号）-2024/2/4

Document: Paclitaxel (nanoparticle albumin-bound) powder for suspension for infusion, 5mg/ml-2025/1/31

Document: European Shortages Monitoring Platform (ESMP) data access policy-2025/3/10

Document: Overview of comments received on the draft revision of EMA’s Policy on handling competing interests of scientific committee members and experts-2025/4/10

Document: Overview of comments received on ICH M11 technical specification during second consultation (EMA/CHMP/ICH/778800/2022)-2025/5/23

Document: Annual activity report 2024-2025/6/27

Page: Dabrafenib product-specific bioequivalence guidance-2025/7/30